info@biomedres.us   +1 (502) 904-2126   One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA   Site Map
ISSN: 2574 -1241

Impact Factor : 0.548

Menu

  Submit Manuscript

Short CommunicationOpen Access

Are You Ready to Take Your Drug Product from Phase I Studies to the Subsequent Phases?

Volume 5 - Issue 5

Francois-Xavier Lacasse*1 and Stephane Lamouche2

  • Author Information Open or Close
    • 1Faculty of Pharmacy, University of Montreal, 2940 Chemin de Polytechnique,Montreal, Quebec, Canada
    • 2SyneosHealthTM, 5160 Boulevard Decarie bureau 800, Montreal, Quebec, Canada

    *Corresponding author: Francois-Xavier Lacasse, Faculty of Pharmacy, University of Montreal, 2940 Chemin de Polytechnique, Montreal, Quebec, Canada

Received: June 16, 2018;   Published: June 20, 2018

DOI: 10.26717/BJSTR.2018.05.001271

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Building a safety assessment package to go into the Phase I clinical stage sounds simple enough.

Short Communication | Absorption, Distribution, Metabolism, Excretion (ADME) | Conclusions and Final Thoughts |

Track Your Article

Member In


View More
Newsletter

Archive


News & Events

  • Submissions are now open for NEXT ISSUE (VOLUME 56 – ISSUE 2), APRIL – 2024 Submit Now

Subject Area

e-books

Reprints

Video Articles